In the groups with different levels of elevated serum AFP, the F-M, H-M and FPHA-M models were more valuable for diagnosing low-level AFP-elevated HCC compared with P-M but with increased false positive rates. The gene discussed is AFP; the disease is hepatocellular carcinoma.